As adeno-associated virus (AAV)-based gene therapies move toward commercialization, traditional characterization methods like analytical ultracentrifugation and electron microscopy can slow manufacturing workflows. Mass photometry offers rapid, low-volume, single-particle analysis, delivering accurate empty, partial, full, and overfilled capsid quantification in under five minutes, with integrated good manufacturing practice (GMP) software to ensure compliance.
Download this whitepaper to explore:
- Mass photometry compared with traditional methods for AAV characterization in manufacturing
- GMP software that provides secure access, audit trails, and electronic signatures
- Automated workflows designed to reduce user bias and improve reproducibility
- Installation, operational, and performance qualification for streamlined validation in GMP environments
